This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Glaxo Group Limited. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Christopher Herring: Innovator in Drug Fusions and Conjugates
Introduction
Christopher Herring is a notable inventor based in Cambridgeshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug fusions and conjugates. His innovative work aims to enhance the efficacy and longevity of therapeutic agents in the human body.
Latest Patents
Herring holds a patent for "Drug fusions and conjugates," which relates to drug fusions that have improved serum half-lives. This invention comprises polypeptides, immunoglobulin (antibody) single variable domains, and GLP and/or exendin molecules. The patent further encompasses various uses, formulations, compositions, and devices that incorporate these drug fusions and conjugates. He has 1 patent to his name.
Career Highlights
Christopher Herring is associated with Glaxo Group Limited, a leading company in the pharmaceutical industry. His work at Glaxo has allowed him to focus on innovative solutions that address critical health challenges. His research and development efforts contribute to the advancement of medical treatments.
Collaborations
Herring has collaborated with notable colleagues, including Lucy J Holt and Laurent S Jespers. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in drug development.
Conclusion
Christopher Herring is a distinguished inventor whose work in drug fusions and conjugates is paving the way for improved therapeutic options. His contributions to the pharmaceutical field are invaluable and continue to impact the industry positively.